Hotflush. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: Intervention group: Folic acid tab 1mg one time a day for 4 weeks. Intervention 2: control group:Placebo tab one time a day for 4 weeks.
Treatment - Drugs
Placebo
Intervention group: Folic acid tab 1mg one time a day for 4 weeks
Sponsors
Vice chancellor for research, Tabriz university of medical science
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Ability to read and write and being able to answer questions;Age range is 45 to 65 years;Elapsing 12 months of last menstral phase;Elapsing 2 months of ovariectomy;Consent to participatein in the study;No history of hormone,antidepressant and anti-anxiety drugs use in the last 2 months;Not using any drugs that affect on hotflash symptom;Not using sulfanamids,sulfasalazine methotrexate,strogen,phenytoin,chemotherapy drugs and multivitamin;Non-malignant,renal,heart,pernicious and aplastic anemia diaeses and hypothyroidism;Exclusion criteria:Failure to complete the questionnaire by the patient more than 3 days;Start an unusual physical activity such as unusually intense exercise.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hotflush frequency. Timepoint: 1 week befor treatment and 1,2,3,4 weeks after treatment. Method of measurement: Hotflush diary.;Hotflush duration. Timepoint: 1 week befor treatment and 1,2,3,4 weeks after treatment. Method of measurement: Hotflush diary.;Hotflush severity. Timepoint: 1 week befor treatment and 1,2,3,4 weeks after treatment. Method of measurement: Hotflush diary. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Farzad-Rik
Tabriz University of Medical Sciences
Outcome results
None listed